ReviewTAG. Theoretical and applied genetics. Theoretische und angewandte Genetik2022
A cool climate perspective on grapevine breeding: climate change and sustainability are driving forces for changing varieties in a traditional market.
Review in TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Optimized protocol for efficient generation, confirmation, transformation, and CRISPR editing of grapevine hairy roots.Journal of experimental botany · 2026Article
- A novel resistance locus from an unexploited East Asian Vitis coignetiae confers resistance to grapevine downy mildew.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026Article
- A multivariate Bayesian modeling strategy coupled with QTL analysis reveals genetic loci linking important sensory wine quality attributes with their corresponding wine aroma compounds.Frontiers in plant science · 2026Article
- Rethinking grapevine downy mildew management: opportunities to disrupt the sexual cycle of the pathogen as a preventive disease control strategy.Frontiers in plant science · 2026Article
- Exploring intra-varietal variation for complex traits in grapevine (Vitis vinifera L.).TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025Article
- Harnessing clonal diversity in grapevine: from genomic insights to modern breeding applications.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025Review
- A new climate for genomic and epigenomic innovation in grapevine.Molecular horticulture · 2025Article
- Chemical and sensory properties of South Tyrol red wines from disease-resistant and Vitis vinifera cultivars.NPJ science of food · 2025Article
- Heat waves reveal additive genetic effects leading to sunburn resilience of grapevine berries.Frontiers in plant science · 2025Article
- Wild Bee Conservation in Viticulture: Effects of Semi-Natural Habitats, Organic Management, and Fungicide Reduction.Ecology and evolution · 2024Article
- A New Approach for CRISPR/Cas9 Editing and Selection of Pathogen-Resistant Plant Cells of Wine Grape cv. 'Merlot'.International journal of molecular sciences · 2024Article
- Genotyping-by-sequencing-based high-resolution mapping reveals a single candidate gene for the grapevine veraison locus Ver1.Plant physiology · 2024Article
- A Sustainable Strategy for Marker-Assisted Selection (MAS) Applied in Grapevine (Plants (Basel, Switzerland) · 2024Article
- Phenotyping grapevine resistance to downy mildew: deep learning as a promising tool to assess sporulation and necrosis.Plant methods · 2024Article
- Enhancing grapevine breeding efficiency through genomic prediction and selection index.G3 (Bethesda, Md.) · 2024Article
- A method for phenotypic evaluation of grapevine resistance in relation to phenological development.Scientific reports · 2024Article
- Origin and pathogenicity variation ofFrontiers in microbiology · 2024Article
- Fungicide-Saving Potential and Economic Advantages of Fungus-Resistant Grapevine Cultivars.Plants (Basel, Switzerland) · 2023Article
- Polyploidization and genomic selection integration for grapevine breeding: a perspective.Frontiers in plant science · 2023Review
- Editorial: Advances in grapevine genetic improvement: Towards high quality, sustainable grape production.Frontiers in plant science · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A multitude of diverse breeding goals need to be combined in a new cultivar, which always forces to compromise. The biggest challenge grapevine breeders face is the extraordinarily complex trait of wine quality, which is the all-pervasive and most debated characteristic. Since the 1920s, Germany runs continuous grapevine breeding programmes. This continuity was the key to success and lead to various new cultivars on the market, so called PIWIs. Initially, introduced pests and diseases such as phylloxera, powdery and downy mildew were the driving forces for breeding. However, preconceptions about the wine quality of new resistant selections impeded the market introduction. These preconceptions are still echoing today and may be the reason in large parts of the viticultural community for: (1) ignoring substantial breeding progress, and (2) sticking to successful markets of well-known varietal wines or blends (e.g. Chardonnay, Cabernet Sauvignon, Riesling). New is the need to improve viticulture´s sustainability and to adapt to changing environmental conditions. Climate change with its extreme weather will impose the need for a change in cultivars in many wine growing regions. Therefore, a paradigm shift is knocking on the door: new varieties (PIWIs) versus traditional varieties for climate adapted and sustainable viticulture. However, it will be slow process and viticulture is politically well advised to pave the way to variety innovation. In contrast to the widely available PIWIs, competitive cultivars created by means of new breeding technologies (NBT, e.g. through CRISPR/Cas) are still decades from introduction to the market.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.